The results suggested that the expression of lipid metabolism–related genes can discriminate TAO patients with high LEPR expression from those with low LEPR expression and that genes such as ACADM, COL15A1 and ADH1C are up‐regulated in TAO patients with high LEPR expression. This evidence concerns the gene ADH1C and thromboangiitis obliterans.